SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
(Translation of Registrant’s Name into English)
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate Offices)
CAMTEK LTD.
(Registrant) By: /s/ Moshe Eisenberg Moshe Eisenberg,
Chief Financial Officer |
![]() |
Camtek Ltd.
P.O.Box 544, Ramat Gabriel Industrial Park
Migdal Ha’Emek 23150, ISRAEL
Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523
E-Mail: [email protected] Web site: http://www.camtek.com
|
CAMTEK LTD.
Moshe Eisenberg, CFO
Tel: +972 4 604 8308
Mobile: +972 54 900 7100
|
INTERNATIONAL INVESTOR RELATIONS
EK Global Investor Relations
Ehud Helft
Tel: (US) 1 212 378 8040 |
MIGDAL HAEMEK, Israel – February 12, 2025 – Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the fourth quarter and year ended December 31, 2024.
• |
Record revenues of $117.3 million, a 32% YoY increase;
|
• |
GAAP operating income of $31.3 million (up 82% YoY) and non-GAAP operating income of $36.3 million (up 42% YoY), representing operating margins of 26.7% and 30.9%, respectively; and
|
• |
GAAP net income of $33.0 million (up 59% YoY) and non-GAAP net income of $37.7 million (up 34% YoY); GAAP diluted EPS of $0.67 and non-GAAP diluted EPS of $0.77.
|
• |
Record revenues of $429.2 million, a 36% YoY increase.
|
• |
GAAP operating income of $108.1 million (up 65% YoY); non-GAAP operating income of $130.3 million (up 56% YoY), representing operating margins of 25.2% and 30.4%, respectively;
|
• |
GAAP net income of $118.5 million (up 51% YoY); non-GAAP net income of $138.6 million (up 45% YoY); GAAP diluted EPS of $2.42 and non-GAAP diluted EPS of $2.83; and
|
• |
Operating cash flow of $122.2 million in 2024, which led to a year-end total cash, short-term and long-term deposits and marketable securities balance of $501.2 million.
|
December 31,
|
December 31,
|
|||||||
2024
|
2023
|
|||||||
U.S. Dollars
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
126,224
|
119,968
|
||||||
Short-term deposits
|
231,000
|
215,250
|
||||||
Marketable securities
|
30,813
|
18,816
|
||||||
Trade accounts receivable, net
|
99,471
|
87,300
|
||||||
Inventories
|
111,204
|
85,905
|
||||||
Other current assets
|
21,347
|
19,548
|
||||||
Total current assets
|
620,059
|
546,787
|
||||||
Long-term deposits
|
26,000
|
21,000
|
||||||
Marketable securities
|
87,115
|
73,576
|
||||||
Long-term inventory
|
11,879
|
9,023
|
||||||
Deferred tax asset, net
|
3,090
|
2,642
|
||||||
Other assets, net
|
2,001
|
1,370
|
||||||
Property, plant and equipment, net
|
54,196
|
41,987
|
||||||
Intangible assets, net
|
13,357
|
16,937
|
||||||
Goodwill
|
74,345
|
74,345
|
||||||
Total non- current assets
|
271,983
|
240,880
|
||||||
Total assets
|
892,042
|
787,667
|
||||||
Liabilities and shareholders’ equity
|
||||||||
Current liabilities
|
||||||||
Trade accounts payable
|
46,630
|
42,187
|
||||||
Other current liabilities
|
77,280
|
54,487
|
||||||
Total current liabilities
|
123,910
|
96,674
|
||||||
Long-term liabilities
|
||||||||
Deferred tax liabilities, net
|
5,606
|
7,541
|
||||||
Other long-term liabilities
|
15,366
|
10,473
|
||||||
Convertible notes
|
197,925
|
196,831
|
||||||
Total long-term liabilities
|
218,897
|
214,845
|
||||||
Total liabilities
|
342,807
|
311,519
|
||||||
Commitments and contingencies
|
||||||||
Shareholders’ equity
|
||||||||
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at December 31, 2024 and at December 31, 2023;
|
||||||||
47,541,682 issued shares at December 31, 2024 and 46,993,998 at December 31, 2023;
|
||||||||
45,449,306 shares outstanding at December 31, 2024 and 44,901,622 at December 31, 2023
|
177
|
176
|
||||||
Additional paid-in capital
|
214,931
|
200,389
|
||||||
Accumulated other comprehensive income
|
203
|
129
|
||||||
Retained earnings
|
335,822
|
277,352
|
||||||
551,133
|
478,046
|
|||||||
Treasury stock, at cost (2,092,376 as of December 31, 2024 and December 31, 2023)
|
(1,898
|
)
|
(1,898
|
)
|
||||
Total shareholders' equity
|
549,235
|
476,148
|
||||||
Total liabilities and shareholders' equity
|
892,042
|
787,667
|
Year ended December 31,
|
Three Months ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
U.S. dollars
|
U.S. dollars
|
|||||||||||||||
Revenues
|
429,234
|
315,375
|
117,293
|
88,690
|
||||||||||||
Cost of revenues
|
219,283
|
167,742
|
59,161
|
48,902
|
||||||||||||
Gross profit
|
209,951
|
147,633
|
58,132
|
39,788
|
||||||||||||
Research and development costs
|
38,287
|
31,470
|
10,371
|
8,042
|
||||||||||||
Selling, general and administrative expense
|
63,595
|
50,751
|
16,461
|
14,527
|
||||||||||||
101,882
|
82,221
|
26,832
|
22,569
|
|||||||||||||
Operating income
|
108,069
|
65,412
|
31,300
|
17,219
|
||||||||||||
Financial income, net
|
23,169
|
22,218
|
6,175
|
5,682
|
||||||||||||
Income before income taxes
|
131,238
|
87,630
|
37,475
|
22,901
|
||||||||||||
Income taxes expense
|
(12,723
|
)
|
(8,998
|
)
|
(4,466
|
)
|
(2,111
|
)
|
||||||||
Net income
|
118,515
|
78,632
|
33,009
|
20,790
|
Year ended December 31,
|
Three Months ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
U.S. dollars
|
U.S. dollars
|
|||||||||||||||
Basic net earnings
|
2.62
|
1.76
|
0.73
|
0.46
|
||||||||||||
Diluted net earnings
|
2.42
|
1.61
|
0.67
|
0.42
|
||||||||||||
Weighted average number of
|
||||||||||||||||
ordinary shares outstanding:
|
||||||||||||||||
Basic
|
45,279
|
44,725
|
45,428
|
44,882
|
||||||||||||
Diluted
|
49,369
|
48,863
|
49,503
|
49,149
|
Year ended December 31,
|
Three Months ended December 31,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
U.S. dollars
|
U.S. dollars
|
|||||||||||||||
Reported net income attributable to Camtek Ltd. on GAAP basis
|
118,515
|
78,632
|
33,009
|
20,790
|
||||||||||||
Acquisition of FRT related expenses (1)
|
5,334
|
4,550
|
650
|
4,550
|
||||||||||||
Share-based compensation
|
14,775
|
12,525
|
4,052
|
2,868
|
||||||||||||
Non-GAAP net income
|
138,624
|
95,707
|
37,711
|
28,208
|
||||||||||||
Non–GAAP net income per diluted share
|
2.83
|
1.96
|
0.77
|
0.57
|
||||||||||||
Gross margin on GAAP basis
|
49.6
|
%
|
46.8
|
%
|
50.6
|
%
|
44.9
|
%
|
||||||||
Reported gross profit on GAAP basis
|
209,951
|
147,633
|
58,132
|
39,788
|
||||||||||||
Acquisition of FRT-related expenses (1)
|
5,802
|
3,492
|
610
|
3,492
|
||||||||||||
Share-based compensation
|
2,197
|
1,591
|
595
|
395
|
||||||||||||
Non-GAAP gross margin
|
50.8
|
%
|
48.4
|
%
|
50.6
|
%
|
49.2
|
%
|
||||||||
Non-GAAP gross profit
|
217,950
|
152,716
|
59,337
|
43,675
|
||||||||||||
Reported operating income (loss) attributable to Camtek Ltd. on GAAP basis
|
108,069
|
65,412
|
31,300
|
17,219
|
||||||||||||
Acquisition of FRT-related expenses (1)
|
7,455
|
5,406
|
928
|
5,406
|
||||||||||||
Share-based compensation
|
14,775
|
12,525
|
4,052
|
2,868
|
||||||||||||
Non-GAAP operating income
|
130,299
|
83,343
|
36,280
|
25,493
|